Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 2:49 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1393–1416 of 1,551 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Ulcerative Clear all

Conditions: Ulcerative Colitis (UC), Inflammatory Bowel Disease
Interventions: Infliximab; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Ulcerative Colitis
Interventions: Mesalamine, Placebo; Drug
Lead sponsor: Ferring Pharmaceuticals; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 228 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 18
States / cities: Little Rock, Arkansas • Murrieta, California • Miami, Florida + 14 more

Conditions: Pressure Ulcer, Pressure Injury, Falls Injury
Interventions: Masimo Centroid System; Device
Lead sponsor: Masimo Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Colitis, Ulcerative
Interventions: Ozanimod; Drug
Lead sponsor: Bristol-Myers Squibb; Industry
Eligibility: 18 Years and older
Enrollment: 139 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 85
States / cities: Dothan, Alabama • Chandler, Arizona • Gilbert, Arizona + 63 more

Conditions: Corneal Ulcers
Interventions: Riboflavin 0.1%, UV-X™ Illumination System; Drug · Other
Lead sponsor: Stephen Trokel; Other
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2015
U.S. locations: 1
States / cities: New York, New York

Conditions: Ulcerative Colitis
Interventions: Adalimumab; Biological
Lead sponsor: AbbVie; Industry
Eligibility: 4 Years to 17 Years
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2025
U.S. locations: 4
States / cities: Orlando, Florida • Minneapolis, Minnesota • Rochester, Minnesota + 1 more

Conditions: Venous Thromboses, Venous Disease, Venous Leg Ulcer, Venous Stasis, Venous Ulcer, Venous Stenosis, Venous Occlusion, Vein Thrombosis
Interventions: GORE® VIABAHN® FORTEGRA Venous Stent; Device
Lead sponsor: W.L.Gore & Associates; Industry
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 4
States / cities: Darien, Connecticut • Washington D.C., District of Columbia • Dallas, Texas + 1 more

Conditions: Venous Stasis Ulcer
Interventions: Erchonia ML Scanner (MLS), Placebo Laser; Device
Lead sponsor: Erchonia Corporation; Industry
Eligibility: 40 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Gastrinoma, Zollinger Ellison Syndrome
Interventions: Pantoprazole, Omeprazole; Drug
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1983 – 2007
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Behcet Syndrome, Behcet Disease
Interventions: Topical Pentoxifylline Gel (Vehicle +PTX), Topical Placebo Gel (Vehicle); Drug
Lead sponsor: Silk Road Therapies, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Gastrointestinal Hemorrhage, Clostridium Difficile Colitis
Interventions: Pantoprazole 40 mg IV daily and tube feed., Placebo and tube feed; Drug · Other
Lead sponsor: Mohamed Saad; Other
Eligibility: 18 Years and older
Enrollment: 124 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Diabetic Foot Ulcer
Interventions: SECONDARY dressing gauze and tape, debridement, irrigation, Dermagraft, Oasis; Device · Procedure
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 85 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2018
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Wound Heal, Diabetic Foot Ulcer
Interventions: EDX110; Device
Lead sponsor: ConvaTec Inc.; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 9
States / cities: Phoenix, Arizona • Los Angeles, California • Santa Ana, California + 6 more

Conditions: Ulcerative Colitis, Ulcerative Colitis Chronic, Inflammatory Bowel Diseases, Crohn's Disease
Interventions: Mirikizumab; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 2 Years to 19 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2030
U.S. locations: 11
States / cities: San Francisco, California • Hartford, Connecticut • Atlanta, Georgia + 7 more

Conditions: Diabetes, PAD, Lower Extremity Edema, Neuropathy;Peripheral, Foot Ulcer, Diabetic, Lymphatic Diseases
Interventions: Avex Footbeat; Device
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Acute and Chronic Wounds, Pressure Ulcers, Trauma Wounds, Diabetic Foot Ulcers, Venous Stasis Ulcers
Interventions: SNaP Wound Care System; Device
Lead sponsor: 3M; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 2
States / cities: Daly City, California

Conditions: Diabetic Foot
Interventions: Bluedrop Monitoring Service (BMS); Device
Lead sponsor: Bluedrop Medical Limited; Industry
Eligibility: 18 Years and older
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Ulcerative Colitis
Interventions: Hydroxocobalamin with Butyrate, Placebo with Butyrate; Drug
Lead sponsor: Joshua Korzenik; Other
Eligibility: 18 Years to 75 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Chestnut Hill, Massachusetts

Conditions: Bacterial Corneal Ulcer
Interventions: ProProKera Plus®; Device
Lead sponsor: University of Arkansas; Other
Eligibility: 18 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Ulcerative Colitis (UC)
Interventions: Mesalamine, Placebo; Drug
Lead sponsor: AbbVie; Industry
Eligibility: 5 Years to 17 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 8
States / cities: Washington D.C., District of Columbia • Jacksonville, Florida • Atlanta, Georgia + 5 more

Conditions: Diabetic Foot Ulcer, Diabetic Foot
Interventions: diabetic foot orthotic, Standard innersole; Device · Other
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Zollinger Ellison Syndrome
Interventions: Not listed
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 18 Years to 100 Years
Enrollment: 273 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 1991
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Diabetic Foot Ulcers
Interventions: Prevention of Pressure Ulcers; Procedure
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2001
U.S. locations: 1
States / cities: New York, New York

Conditions: Diabetic Ulcers on Both Feet, Amputation; Traumatic, Limb, Sexual Dysfunction, Diabetic Foot Ulcer Ischemic
Interventions: Diabetes education; Behavioral
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: The Bronx, New York

Search by objective public record fields.

Early Serum Infliximab Levels in Severe Ulcerative Colitis.

Mesalamine 4 g Sachet for the Induction of Remission in Active, Mild to Moderate Ulcerative Colitis (UC)

Usability Validation of Patient Monitoring Device for Pressure Injury Prevention and Fall Detection

An Open-label Study of Ozanimod in Moderate to Severe Ulcerative Colitis in Clinical Practice

Safety and Effectiveness of the UV-X System for Corneal Collagen Cross-Linking in Eyes With Refractory Corneal Infection

Long-term Safety and Efficacy Study of Adalimumab in Pediatric Subjects With Ulcerative Colitis

The GORE® VIABAHN® FORTEGRA Venous Stent Post-Approval Study

Efficacy Study of the Application of Low Level Laser Light to Treat Venous Stasis Ulcers

The Use of Oral Omeprazole and Intravenous Pantoprazole in Patients With Hypersecretion of Gastric Acid

Topical Pentoxifylline Gel on Behcet's Disease Genital Ulcers

Enteral Nutrition as Stress Ulcer Prophylaxis in Critically Ill Patients.

VA MERIT: A Comparative Efficacy Study: Treatment of Non-Healing Diabetic

EDX110 Randomized Control Trial for Treatment of DFUs

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

Micro-mobile Foot Compression and Diabetic Foot

Clinical Evaluation of the SNaP Wound Care System

Remote Monitoring of the Diabetic Foot to Prevent Re-Ulceration

Hydroxocobalamin Approach for Reducing of Calprotectin With Butyrate for Ulcerative Colitis Remission

Evaluating the Use of ProKera Plus® in the Management of Bacterial Corneal Ulcers

A Study to Assess Adverse Events and Change in Disease Condition of Mesalamine Capsules in Children Aged 5 to 17 Years With Ulcerative Colitis

Multi-layer Insoles for a Patient-specific Approach to Shear and Pressure Reduction in Diabetes-related Foot Ulcer

Evaluating Pancreatic Tumors in Patients With Zollinger-Ellison Syndrome

Investigation of Subatmospheric Pressure Dressing on Pressure Ulcer Healing

The Impact of Sexual Health and Amputation Focused Education on Regulation of Glucose and Amputation Prevention